John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 14,351 shares at $68.35 ($994K) on 2016-01-20, disclosed to the SEC on 2016-01-21.
Open-market sale of $994k ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.28 | 1,200 | $80K | 8.0% |
| 2 | $67.39 | 2,700 | $182K | 18.3% |
| 3 | $68.35 | 4,406 | $301K | 30.3% |
| 4 | $69.40 | 2,114 | $147K | 14.8% |
| 5 | $70.43 | 930 | $66K | 6.6% |
| 6 | $71.79 | 1,136 |
| $82K |
| 8.2% |
| 7 | $73.77 | 1,865 | $138K | 13.8% |
| Total | $69.26 avg | 14,351 | $994K | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |